Insider Transactions last 24 months for KalVista Pharmaceuticals, Inc.  -  NSDQ: KALV

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Venrock Healthcare Capital Partners Iii, L.P.Other03/26/2026DSIndirectCOM3,183$19.12$60,858.965,089,354
Venrock Healthcare Capital Partners Iii, L.P.Other03/26/2026DSIndirectCOM15,417$18.82$290,147.945,092,537
Venrock Healthcare Capital Partners Iii, L.P.Other03/26/2026DSIndirectCOM21,386$17.76$379,815.365,107,954
Venrock Healthcare Capital Partners Iii, L.P.Other03/25/2026DSIndirectCOM160$17.53$2,804.805,129,340
Venrock Healthcare Capital Partners Iii, L.P.Other03/25/2026DSIndirectCOM174,485$16.95$2,957,520.755,129,500
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER03/09/2026DSDirectCOM6,693$16.08$107,632.81451,815
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER03/06/2026AMDirectCOM15,625$0.00$0.00458,508
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER02/23/2026DSDirectCOM10,034$15.57$156,197.27442,883
Yea ChristopherCHIEF DEVELOPMENT OFFICER02/23/2026DSDirectCOM4,347$15.57$67,668.88226,701
Piekos BrianChief Financial Officer02/23/2026DSDirectCOM1,767$15.57$27,506.5413,762
Sweeny NicoleChief Commercial Officer02/23/2026DSDirectCOM3,975$15.57$61,878.0347,003
Audhya Paul K.CHIEF MEDICAL OFFICER02/23/2026DSDirectCOM5,354$15.57$83,344.65138,983
Yea ChristopherCHIEF DEVELOPMENT OFFICER02/22/2026AMDirectCOM3,125$0.00$0.00231,048
Sweeny NicoleChief Commercial Officer02/22/2026AMDirectCOM5,000$0.00$0.0050,978
Audhya Paul K.CHIEF MEDICAL OFFICER02/22/2026AMDirectCOM5,000$0.00$0.00144,337
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER02/21/2026AMDirectCOM23,250$0.00$0.00452,917
Yea ChristopherCHIEF DEVELOPMENT OFFICER02/21/2026AMDirectCOM3,750$0.00$0.00227,923
Piekos BrianChief Financial Officer02/21/2026AMDirectCOM5,000$0.00$0.0015,529
Sweeny NicoleChief Commercial Officer02/21/2026AMDirectCOM6,250$0.00$0.0045,978
Audhya Paul K.CHIEF MEDICAL OFFICER02/21/2026AMDirectCOM6,250$0.00$0.00139,337
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER02/18/2026DSDirectCOM1,038$15.00$15,570.00429,667
Yea ChristopherCHIEF DEVELOPMENT OFFICER02/18/2026DSDirectCOM1,109$15.00$16,635.00224,173
Audhya Paul K.CHIEF MEDICAL OFFICER02/18/2026DSDirectCOM1,163$15.00$17,445.00133,087
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER02/17/2026AMDirectCOM2,419$0.00$0.00430,705
Yea ChristopherCHIEF DEVELOPMENT OFFICER02/17/2026AMDirectCOM1,774$0.00$0.00225,282
1   2  3  4  5  6  7  Next Last  You are at page 1 of 7 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel